Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer
Molecular Therapy · 2025-03 · 33 (3) · 997-1013
DOI: 10.1016/j.ymthe.2025.01.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2025-03. Verfasst von Weijie Du und 20 weiteren Autor:innen. Beteiligte Einrichtung: Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universitä…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, CD3 Complex, Gene Editing, Adoptive Transfer. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council, Horizon 2020 Framework Programme, European Health and Digital Executive Agency.
Abstract (Originalsprache)
Adoptive transfer of antigen-specific regulatory T cells (Tregs) is a promising strategy to combat immunopathologies in transplantation and autoimmune diseases. However, their low frequency in peripheral blood poses challenges for both manufacturing and clinical application. Chimeric antigen receptors have been used to redirect the specificity of Tregs, using retroviral vectors. However, retroviral gene transfer is costly, time consuming, and raises safety issues. Here, we explored non-viral CRISPR-Cas12a gene editing to redirect Tregs, using human leukocyte antigen (HLA)-A2-specific constructs for proof-of-concept studies in transplantation models. Knock-in of an antigen-binding domain into the N terminus of CD3 epsilon (CD3ε) gene generates Tregs expressing a chimeric CD3ε-T cell receptor fusion construct (TRuC) protein that integrates into the endogenous TCR/CD3 complex. These CD3ε-TRuC Tregs exhibit potent antigen-dependent activation while maintaining responsiveness to TCR/CD3 stimulation. This enables preferential enrichment of TRuC-redirected Tregs over CD3ε knockout Tregs via repetitive CD3/CD28 stimulation in a good manufacturing practice-compatible expansion system. CD3ε-TRuC Tregs retained their phenotypic, epigenetic, and functional identity. In a humanized mouse model, HLA-A2-specific CD3ε-TRuC Tregs demonstrate superior protection of allogeneic HLA-A2+ skin grafts from rejection compared with polyclonal Tregs. This approach provides a pathway for developing clinical-grade CD3ε-TRuC-based Treg cell products for transplantation immunotherapy and other immunopathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), 13353 Berlin, Germa…
- Department of Gastroenterology, Infectious Diseases and Hepatology & Endocrinology, Hannover Medical School, Hannover, Germany.
- Transplantation Research and Immunology Group, Nuffield Department of Surgical Science, University of Oxford, Oxford OX3 9DU, UK.
- Institute for Transfusion Medicine and Gene Therapy, Medical Center, University of Freiburg, 79106 Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center, University of Freiburg, 79106 Freiburg, Germany;…
- BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health at Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany.
- Institute of Molecular Medicine and Experimental Immunology (IMMEI), University of Bonn, Biomedical Center II, Venusberg Campus 1, 53127 Bonn, Germany.
Förderung
- European Research Council
- Horizon 2020 Framework Programme
- European Health and Digital Executive Agency
Zitieren
APA
Du, W., Noyan, F., McCallion, O., Drosdek, V., Kath, J., Glaser, V., Fuster-Garcia, C., Yang, M., Stein, M., Franke, C., Pu, Y., Weber, O., Polansky, J. K., Cathomen, T., Jaeckel, E., Hester, J., Issa, F., Volk, H. D., Schmueck-Henneresse, M., …, & Wagner, D. L. (2025). Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer. Molecular Therapy, 33(3), 997-1013. https://doi.org/10.1016/j.ymthe.2025.01.045
Vancouver
Du W, Noyan F, McCallion O, Drosdek V, Kath J, Glaser V, et al. Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer. Molecular Therapy. 2025;33(3):997-1013. doi:10.1016/j.ymthe.2025.01.045
BibTeX
@article{Du2025,
author = {Du, Weijie and Noyan, Fatih and McCallion, Oliver and Drosdek, Vanessa and Kath, Jonas and Glaser, Viktor and Fuster-Garcia, Carla and Yang, Mingxing and Stein, Maik and Franke, Clemens and Pu, Yaolin and Weber, Olaf and Polansky, Julia K and Cathomen, Toni and Jaeckel, Elmar and Hester, Joanna and Issa, Fadi and Volk, Hans-Dieter and Schmueck-Henneresse, Michael and Reinke, Petra and Wagner, Dimitrios L},
title = {Gene editing of CD3 epsilon to redirect regulatory T cells for adoptive T cell transfer},
journal = {Molecular Therapy},
year = {2025},
volume = {33},
number = {3},
pages = {997--1013},
doi = {10.1016/j.ymthe.2025.01.045}
}
EUVIMED